Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price dropped 8.2% on Thursday . The company traded as low as C$0.45 and last traded at C$0.45. Approximately 100,878 shares traded hands during trading, an increase of 162% from the average daily volume of 38,452 shares. The stock had previously closed at C$0.49.
Crescita Therapeutics Stock Performance
The company has a debt-to-equity ratio of 5.77, a quick ratio of 2.29 and a current ratio of 2.70. The company has a market capitalization of C$8.56 million, a P/E ratio of 23.00 and a beta of -0.26. The business’s fifty day simple moving average is C$0.48 and its 200-day simple moving average is C$0.47.
About Crescita Therapeutics
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
Featured Articles
- Five stocks we like better than Crescita Therapeutics
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
